Categories Uncategorized

Cyberattacks: How to Up Your Cybersecurity Game for Medical Devices

In the healthcare industry, cyberattacks have become very common. This is mainly due to the increase in the networked medical devices. This is prompting device manufacturers to constantly reduce threats that would affect the devices’ security.

Many medical devices have embedded computer systems that are susceptible to security breaches which can affect how they operate. The rise in cyberattacks led to the FDA issuing a warning in March 2019, concerning 2 security flaws that affected implantable cardioverter defibrillators.

To better understand the risks a compromise in device security may have on an individual, we first look at how the attacks are launched.

When malware is introduced into an equipment or gains unauthorized access to a device’s data or configuration settings as well as the networks to which the said devices are connected, this is considered a cyberattack.

These attacks may result in data collection and transmission, which compromises patient safety, especially when it comes to devices such as insulin pumps and defibrillators, as malicious software could cause malfunctions that may result in patient harm or sometimes, death.

Furthermore, the access of data from networked devices through hacking may also disclose critical information. For example:

  • Data from other devices which are connected to the same network which expands the range of patient safety that has been compromised
  • Health data of patients, this information can be sold or used to aid in identity theft
  • Data of a product’s performance, this data can be sold to competitors or used to compromise a manufacturers’ efficacy and safety claims

Factors that can also pitch in to cybersecurity risks of devices in the medical sector include:

  • Lack of authority for health care centers to stop using devices that are no longer supported by the manufacturer
  • Using off-the-shelf software
  • Advancements in the Internet of Things; this blurs the lines between private and public data, thus making it easier for personal health data to be shared electronically

A survey that was done recently showed that 62% of consumers valued cybersecurity more than the ease of use of a medical device. Device manufacturers should therefore bear the responsibility of ensuring their device security. An effective cybersecurity plan should include both postmarket and premarket phases while also addressing risk management from device conception and use to disposal.

On the other hand, hospitals and other healthcare facilities should constantly evaluate and update their network security software and protect their systems diligently using guidelines that should be issued by the device manufacturing companies.

Experts say sector startups would do well to learn how companies like DarioHealth Corp. (NASDAQ: DRIO) safely offer their smartphone-centered, personalized chronic illness management software-as-a-service (“SaaS”).

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

The Global Market for Brain Tumor Treatments Will Reach $7.15 Billion by 2035

The global market for brain tumor treatments is experiencing significant transformation powered by advances in…

2 days ago

New Blood Test Shows Potential in Revolutionizing Early Parkinson’s Detection

A team of researchers has developed a “cost-effective” and simple blood test with the potential…

4 days ago

Nutriband Inc. (NASDAQ: NTRB) Is ‘One to Watch’

Nutriband’s AVERSA technology has the potential to improve the safety profile of transdermal drugs susceptible…

4 days ago

Nutriband Inc. (NASDAQ: NTRB) Leading the Way in Transformative Partnerships Formed in Growing Pharma Sector

Strategic partnerships embrace opportunities to foster innovation, streamline processes and ultimately improve the lives of…

5 days ago

Adageis Helps Medical Providers Track and Build Revenue Through Efficient Application of Value-Based Care

Adageis provides clinics and medical groups with AI-powered tools to track financial outcomes tied to…

1 week ago

Blocking an Enzyme in Melanoma Patients Could Overcome Resistance to Immunotherapy

Approximately 65% of patients diagnosed with melanoma are unresponsive to immunotherapy. New research suggests that…

1 week ago